Drugs & Side Effects |

Cancer Drugs News

New Bowel Cancer Drugs Not Funded in Britain

RSS News Feeds
Drugs & Pharmacuticals
Cancer Drugs
Fosamax
 All RSS Feeds

At a glance:

Britain's National Health Service will not currently fund two new bowel cancer drugs, bevacizumab (Avastin) and cetuximab (Erbitux). 
 
Cancer advocacy groups and charities oppose this decision, saying it is financially motivated and that the drugs prolong the lives of patients with advanced cancers. Those behind the decision claim that the benefits do not yet justify the cost according to current evidence. 
 
A decision is still pending in Britain for the breast cancer drug, Herceptin.

Bowel cancer drugs denied NHS funding

Guardian Unlimited - 6/2/2006 8:28 PM

Cancer charities were dismayed yesterday by a preliminary decision from the government's drug watchdog against funding new bowel cancer drugs on the NHS.
 
Bowel cancer is the second biggest killer after lung cancer, affecting about 35,000 people a year. The drugs bevacizumab (sold under the brandname Avastin) and cetuximab (Erbitux) promise longer life, but not a cure, for about 9,000 people in advanced stages of the disease
 
· Read The Full Cancer Drugs Article From Guardian Unlimited -->

· Read All Cancer Drugs News Stories -->

Comments On Cancer Drugs News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: